Overview

Autoinjector Device Assessment Study

Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
Phase I study to determine the device-related injection failure rate of the single-use, pre-filled autoinjector.
Phase:
Phase 1
Details
Lead Sponsor:
AstraZeneca
Collaborator:
Celerion
Treatments:
Exenatide